Tech Company Financing Transactions

Phase Genomics Funding Round

On 3/5/2024, Phase Genomics raised $1.5 million in funding from Bill & Melinda Gates Foundation.

Transaction Overview

Company Name
Announced On
3/5/2024
Transaction Type
Venture Equity
Amount
$1,500,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to develop a new antimicrobial discovery platform.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Unddisclosed
Seattle, WA 98101
USA
Phone
Undisclosed
Email Address
Overview
Phase Genomics' mission is to help scientists make breakthrough discoveries by providing the most complete, accurate, detailed genomes and metagenomes available from any technology.
Profile
Phase Genomics LinkedIn Company Profile
Social Media
Phase Genomics Company Twitter Account
Company News
Phase Genomics News
Facebook
Phase Genomics on Facebook
YouTube
Phase Genomics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Ivan Liachko
  Ivan Liachko LinkedIn Profile  Ivan Liachko Twitter Account  Ivan Liachko News  Ivan Liachko on Facebook
Chief Technical Officer
Shawn Sullivan
  Shawn Sullivan LinkedIn Profile  Shawn Sullivan Twitter Account  Shawn Sullivan News  Shawn Sullivan on Facebook
VP - Operations
Kayla Young
  Kayla Young LinkedIn Profile  Kayla Young Twitter Account  Kayla Young News  Kayla Young on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/5/2024: Limbic venture capital transaction
Next: 3/5/2024: Yuno venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to record tech company VC transactions. VC investment data records on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary